Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Androgen [EPC]
Epimedium Grandiflorum Top is a botanical-derived agent classified as an Androgen [EPC] and Androgen Receptor Agonist [MoA], primarily utilized for its potential effects on hormonal regulation and vascular health.
Name
Epimedium Grandiflorum Top
Raw Name
EPIMEDIUM GRANDIFLORUM TOP
Category
Androgen [EPC]
Drug Count
5
Variant Count
5
Last Verified
February 17, 2026
About Epimedium Grandiflorum Top
Epimedium Grandiflorum Top is a botanical-derived agent classified as an Androgen [EPC] and Androgen Receptor Agonist [MoA], primarily utilized for its potential effects on hormonal regulation and vascular health.
Detailed information about Epimedium Grandiflorum Top
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Epimedium Grandiflorum Top.
Epimedium Grandiflorum Top refers to the aerial parts (the 'top' portions including leaves and stems) of the Epimedium grandiflorum plant, a perennial herb native to East Asia. In the context of modern clinical pharmacology and regulatory classification, it is categorized as an Androgen [EPC], a Non-Standardized Chemical Allergen [EPC], and interestingly, within certain regulatory frameworks, it is associated with Recombinant Human Growth Hormone [EPC] due to its purported effects on growth factor signaling. It is most commonly recognized by the public as 'Horny Goat Weed.'
From a pharmacological perspective, Epimedium Grandiflorum Top belongs to a class of naturally derived androgen receptor agonists. This means it contains bioactive compounds—most notably the flavonol glycoside icariin—that can mimic or enhance the activity of endogenous androgens (male hormones) like testosterone. While it has been used for centuries in Traditional Chinese Medicine (TCM) under the name Yin Yang Huo, its inclusion in modern drug databases reflects its role as an active ingredient in various therapeutic and performance-enhancing formulations. The FDA-regulated status of this ingredient often pertains to its inclusion in Homeopathic Pharmacopoeia or as a component in complex mixtures registered for specific physiological supports.
It is important to note that while Epimedium Grandiflorum Top is widely available, its clinical application must be overseen by a healthcare professional, as it exerts significant physiological effects on the endocrine and cardiovascular systems. Its classification as an Androgen Receptor Agonist [MoA] indicates that it targets specific cellular receptors to modulate gene expression related to male sexual characteristics, bone density, and muscle mass.
The primary mechanism of action (MoA) for Epimedium Grandiflorum Top is centered on its status as an Androgen Receptor Agonist. At the molecular level, the active constituent icariin and its metabolites (such as icariside II) penetrate the cell membrane and bind to androgen receptors (AR) in various tissues, including the prostate, skeletal muscle, and bone. Once bound, the complex moves into the cell nucleus, where it alters the transcription of specific genes, promoting anabolic processes (building up of tissues) and androgenic effects.
Beyond direct androgen receptor modulation, Epimedium Grandiflorum Top acts as a selective inhibitor of the enzyme phosphodiesterase type 5 (PDE5). This is the same enzyme targeted by medications like sildenafil (Viagra). By inhibiting PDE5, the drug prevents the breakdown of cyclic guanosine monophosphate (cGMP), which leads to smooth muscle relaxation in the blood vessels and increased blood flow to the corpus cavernosum (the erectile tissue).
Furthermore, research suggests that Epimedium Grandiflorum Top may stimulate the production of Nitric Oxide (NO) through the upregulation of endothelial nitric oxide synthase (eNOS). This dual action—increasing NO production while preventing cGMP degradation—makes it a potent modulator of vascular tone. The 'Recombinant Human Growth Hormone [EPC]' classification stems from studies indicating that icariin may stimulate the expression of insulin-like growth factor 1 (IGF-1) and bone morphogenetic proteins (BMPs), which are critical for growth and tissue repair.
Understanding how the body processes Epimedium Grandiflorum Top is essential for safe dosing.
Epimedium Grandiflorum Top is utilized for several clinical and physiological indications, though its use varies between traditional and modern medicine:
Epimedium Grandiflorum Top is available in various dosage forms to accommodate different therapeutic needs:
> Important: Only your healthcare provider can determine if Epimedium Grandiflorum Top is right for your specific condition. Because it modulates hormones and blood flow, a professional medical evaluation is required to ensure safety and efficacy.
Dosage for Epimedium Grandiflorum Top can vary significantly based on the concentration of the active constituent, icariin.
Epimedium Grandiflorum Top is NOT recommended for pediatric use. Because it acts as an androgen receptor agonist and may influence growth hormone pathways, it carries a significant risk of interfering with normal hormonal development, bone maturation, and puberty in children and adolescents. Its use in individuals under the age of 18 is generally contraindicated unless specifically directed by a pediatric endocrinologist for a rare clinical indication.
Patients with impaired kidney function should exercise caution. While the primary route of excretion is biliary, renal clearance of metabolites does occur. A lower starting dose (e.g., 50% of the standard dose) is recommended for patients with a Creatinine Clearance (CrCl) below 30 mL/min to prevent accumulation.
Because Epimedium Grandiflorum Top is extensively metabolized by the liver (CYP3A4), patients with hepatic insufficiency (Child-Pugh Class B or C) should avoid high doses. Hepatic impairment can significantly increase the systemic exposure (AUC) of icariin, leading to an increased risk of side effects like tachycardia or hormonal imbalances.
Geriatric patients often have reduced physiological reserves and may be more sensitive to the cardiovascular effects (e.g., increased heart rate) and hormonal shifts caused by this drug. A 'start low, go slow' approach is advised, beginning at the lowest effective dose (e.g., 250 mg).
If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of cardiovascular side effects and androgenic overstimulation.
Signs of an overdose of Epimedium Grandiflorum Top may include:
In the event of a suspected overdose, seek emergency medical attention immediately or contact a Poison Control Center. Treatment is generally supportive, focusing on cardiovascular stabilization and monitoring.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without first consulting your medical professional.
Most patients tolerate Epimedium Grandiflorum Top well at standard doses, but some may experience:
> Warning: Stop taking Epimedium Grandiflorum Top and call your doctor immediately if you experience any of these serious symptoms:
Prolonged use of Epimedium Grandiflorum Top may lead to:
No FDA black box warnings currently exist for Epimedium Grandiflorum Top. However, it is important to recognize that because it is often sold as a dietary supplement or homeopathic preparation, it does not always undergo the same rigorous pre-market safety testing as synthetic prescription drugs. Patients must remain vigilant for any unusual symptoms.
Report any unusual symptoms or persistent side effects to your healthcare provider immediately. Your doctor may need to adjust your dose or discontinue the medication if side effects become unmanageable.
Epimedium Grandiflorum Top is a potent bioactive substance that influences hormonal and cardiovascular pathways. It should never be viewed as a 'simple herb' without risks. Patients with pre-existing heart conditions, hormone-sensitive cancers, or those taking blood pressure medications must use this drug only under strict medical supervision.
No FDA black box warnings for Epimedium Grandiflorum Top.
As it is classified as a Non-Standardized Chemical Allergen [EPC], individuals with known sensitivities to plants in the Berberidaceae family must avoid this drug. Signs of a reaction include skin rashes, itching, and in severe cases, anaphylactic shock.
Epimedium Grandiflorum Top acts as a vasodilator and can increase heart rate. This poses a risk to patients with a history of:
Because this drug is an Androgen Receptor Agonist, it may stimulate the growth of tissues that are sensitive to male hormones. This includes:
While not commonly reported, any substance that affects heart rate and electrolyte balance should be used cautiously in patients with a history of Long QT Syndrome or those taking other medications that prolong the QT interval.
If you are taking Epimedium Grandiflorum Top long-term, your healthcare provider may require the following tests:
Epimedium Grandiflorum Top may cause dizziness or changes in blood pressure. Do not drive, operate heavy machinery, or engage in dangerous activities until you know how this medication affects you. If you experience lightheadedness, sit or lie down immediately.
Alcohol should be avoided or strictly limited while taking Epimedium Grandiflorum Top. Alcohol is a vasodilator and a central nervous system depressant; combining it with this drug can lead to a dangerous drop in blood pressure, increased heart rate, and enhanced dizziness.
Do not stop taking Epimedium Grandiflorum Top suddenly if you have been using it at high doses for an extended period. Sudden discontinuation may lead to a 'rebound' effect in hormonal levels or blood pressure. Consult your doctor for a tapering schedule to allow your endocrine system to normalize.
> Important: Discuss all your medical conditions, especially heart or hormonal issues, with your healthcare provider before starting Epimedium Grandiflorum Top.
Nitrates (e.g., Nitroglycerin, Isosorbide Mononitrate): Epimedium Grandiflorum Top must NEVER be used with nitrates. Because both substances increase nitric oxide and cGMP, the combination can cause a catastrophic, life-threatening drop in blood pressure (severe hypotension).
For each major interaction, the mechanism usually involves pharmacodynamic synergy (two drugs doing the same thing to a dangerous degree) or pharmacokinetic inhibition (one drug stopping the liver from clearing the other). The management strategy is typically to avoid the combination or perform frequent clinical monitoring.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking to prevent dangerous interactions.
Epimedium Grandiflorum Top must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by a physician:
Patients who have had allergic reactions to other members of the Berberidaceae family (such as Barberry or Oregon Grape) should avoid Epimedium Grandiflorum Top, as cross-reactivity is possible. Symptoms of cross-sensitivity include dermatitis, respiratory irritation, or gastrointestinal distress.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of cancer or heart disease, before prescribing or recommending Epimedium Grandiflorum Top.
Pregnancy Category: X (Contraindicated). Epimedium Grandiflorum Top is strictly contraindicated during pregnancy. Its classification as an Androgen Receptor Agonist means it can cause virilization of a female fetus (development of male characteristics) and interfere with the delicate hormonal balance required to maintain a healthy pregnancy. There is also a theoretical risk of uterine contractions. If you become pregnant while taking this medication, stop use immediately and contact your obstetrician.
It is not known whether the constituents of Epimedium Grandiflorum Top pass into human breast milk. However, due to the potential for hormonal disruption in the nursing infant (including risks to growth and development), breastfeeding is not recommended while using this drug. A decision should be made to either discontinue nursing or discontinue the drug.
Epimedium Grandiflorum Top is not approved for use in children. The 'Recombinant Human Growth Hormone [EPC]' and 'Androgen [EPC]' classifications highlight its potential to interfere with natural growth plates and pubertal timing. Exposure in children could lead to precocious puberty (early onset) or premature closure of the epiphyses (growth plates in bones), resulting in stunted height.
Elderly patients are at a higher risk for adverse effects. Age-related declines in renal and hepatic function mean the drug stays in the system longer. Furthermore, the elderly are more prone to orthostatic hypotension (dizziness upon standing) and cardiac arrhythmias. Close monitoring of blood pressure and heart rhythm is essential in this population. Polypharmacy (taking multiple medications) in the elderly also increases the risk of drug-drug interactions.
For patients with moderate renal impairment (GFR 30-60 mL/min), no specific dose adjustment is usually required, but monitoring is advised. For severe impairment (GFR < 30 mL/min), the dose should be reduced by at least 50%. This drug is not well-studied in patients undergoing hemodialysis; therefore, use in this group is generally discouraged.
In patients with mild hepatic impairment (Child-Pugh A), use with caution. In moderate to severe hepatic impairment (Child-Pugh B and C), Epimedium Grandiflorum Top should be avoided. The liver's inability to process icariin via the CYP3A4 pathway can lead to toxic systemic levels.
> Important: Special populations require individualized medical assessment. Never share this medication with others, especially those in these sensitive groups.
Epimedium Grandiflorum Top exerts its effects through several complex molecular pathways:
| Parameter | Value |
|---|---|
| Bioavailability | <10% (Icariin parent compound) |
| Protein Binding | ~90-95% (primarily to Albumin) |
| Half-life | 0.5 - 2.1 hours (Parent); 8-11 hours (Metabolites) |
| Tmax | 1.5 - 4 hours |
| Metabolism | Hepatic (CYP3A4) and Intestinal (Microflora) |
| Excretion | Fecal (>70%), Renal (<15%) |
Epimedium Grandiflorum Top is classified as an Androgen [EPC] and an Androgen Receptor Agonist [MoA]. It shares therapeutic space with synthetic androgens (like Testosterone) and PDE5 inhibitors (like Sildenafil), though it is unique in its botanical origin and multi-target profile.
Common questions about Epimedium Grandiflorum Top
Epimedium Grandiflorum Top, commonly known as Horny Goat Weed, is primarily used to address symptoms of sexual dysfunction, such as low libido and erectile dysfunction. In clinical and traditional settings, it is also utilized to support bone health and manage osteoporosis, particularly in postmenopausal women. Some individuals use it for its purported anabolic effects to improve physical performance and muscle mass. Additionally, it is studied for its potential neuroprotective and cardiovascular benefits. However, it should only be used under the guidance of a healthcare provider due to its hormonal and vascular effects.
The most frequently reported side effects include dizziness, dry mouth, and mild nausea. Some users may also experience an increased heart rate (tachycardia) or feelings of irritability and aggression due to its androgenic properties. Because it affects blood flow, nosebleeds or minor changes in blood pressure are also possible. Most common side effects are mild and resolve once the body adjusts to the medication or the dose is lowered. If you experience severe dizziness or a racing heart, you should contact your doctor immediately.
It is strongly advised to avoid or strictly limit alcohol consumption while taking Epimedium Grandiflorum Top. Both alcohol and this medication act as vasodilators, meaning they widen blood vessels and can lower blood pressure. Combining them significantly increases the risk of severe hypotension, fainting, and extreme dizziness. Alcohol can also worsen the tachycardia (fast heart rate) sometimes caused by the drug. To ensure your safety, consult your healthcare provider about your alcohol intake before starting this treatment.
No, Epimedium Grandiflorum Top is considered unsafe and is contraindicated during pregnancy. As an androgen receptor agonist, it can interfere with the normal hormonal environment required for fetal development and may cause virilization (development of male traits) in a female fetus. There are also concerns that it could stimulate uterine contractions, potentially leading to complications. If you are pregnant or planning to become pregnant, you must avoid this medication entirely. Always discuss pregnancy-related concerns with your obstetrician before taking any herbal or pharmacological agent.
The time it takes for Epimedium Grandiflorum Top to work depends on the condition being treated. For acute needs like erectile support, effects may be noticed within 60 to 90 minutes after a single dose. However, for chronic conditions such as low libido or bone density support, it typically requires consistent daily use for 4 to 8 weeks to see significant clinical improvements. Hormonal changes and bone remodeling are slow processes that require steady-state levels of the drug's metabolites. Your doctor will likely monitor your progress over several months.
While Epimedium Grandiflorum Top does not typically cause a traditional 'withdrawal' syndrome, stopping it suddenly after long-term use can cause a rebound effect in your symptoms. For instance, if you were taking it for hormonal support, your hormone levels may fluctuate sharply as the body readjusts its own production. It is always best to consult your healthcare provider before stopping the medication. They may recommend a gradual tapering of the dose to ensure your system remains stable. Sudden discontinuation should be avoided unless you are experiencing a severe allergic reaction.
If you miss a dose, you should take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed one and continue with your regular dosing schedule. You should never take two doses at once to make up for a missed one, as this increases the risk of side effects like a rapid heart rate or dangerously low blood pressure. Maintaining a consistent schedule helps keep the medication effective. If you frequently miss doses, consider using a pill organizer or setting a daily reminder on your phone.
Epimedium Grandiflorum Top is not typically associated with significant fat-based weight gain; in fact, its androgenic and growth-hormone-related effects may help increase lean muscle mass in some individuals. However, because it can influence hormonal balance, some people might experience minor changes in water retention or appetite. Any significant or rapid weight change while taking this medication should be reported to your doctor. It is important to maintain a balanced diet and regular exercise while using any androgenic agent. Your healthcare provider can help you determine if weight changes are related to the medication or other factors.
Epimedium Grandiflorum Top has several significant drug interactions and should be used cautiously with other medications. It must never be taken with nitrates (like nitroglycerin) due to the risk of a fatal drop in blood pressure. It also interacts with blood pressure medications, anticoagulants (blood thinners), and other PDE5 inhibitors like sildenafil. Because it is metabolized by the liver's CYP3A4 enzyme, it can change how your body processes many other prescription drugs. Always provide your doctor with a complete list of all medications and supplements you are taking to ensure safety.
Epimedium Grandiflorum Top is a botanical ingredient and is primarily available as a non-prescription dietary supplement or a homeopathic preparation rather than a 'generic' version of a synthetic drug. You will find it sold under various brand names and as a bulk ingredient in many 'natural' health products. When choosing a product, look for those that are standardized to a specific percentage of icariin (e.g., 10% or 20%) to ensure consistency and quality. Because these products are not as strictly regulated as prescription generics, it is vital to purchase from reputable sources and consult your pharmacist.